Real-world data indicate lower adherence rates for breast cancer endocrine therapy when radiation therapy is omitted

Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy, a large U.S. insurance claims analysis indicates. The findings provide real-world context for treatment approaches that consider omitting radiation therapy, which typically rely on the expectation that patients will continue taking medication for at least five years.

Read it at Medical Xpress ↗

← Front page